Amogelang Raphenya makes his triumphant return to the top of the leaderboard!
Author: agmcarthur
Baker, S.J.C., J. Maciejewski, M.-T. Usuanlele, J. Gilchrist, D.R. Sharma, D. Bulir, M. Smieja, M. Loeb, M.G. Surette, A.G. McArthur, & D. Mertz. 2023. Investigating
Jacob et al. Emerg Infect Dis. 2023 Jun 12;29(7). Isolating and characterizing emerging SARS-CoV-2 variants is key to understanding virus pathogenesis. In this study, we
While many know of Amogelang (Amos) Raphenya as the Lead CARD Developer and a local, national, and international resource for genomic surveillance of antimicrobial resistance,
Colin Bruce joins us by way of the laboratory of Dr. Jennifer Stearns and will be completing the last year of his PhD studies with
Today the Comprehensive Antibiotic Resistance Database turns 10 years old! While it started a few years before this in the laboratory of Dr. Gerry Wright,
CARD and CZ ID are thrilled to launch a new CZ ID module that allows researchers to detect and analyze antimicrobial resistance (AMR) genes in
The SARS-CoV-2 Illumina GeNome Assembly Line (SIGNAL) has been updated to version 1.6.2, with an important hotfix to address software version incompatibility for rules using
Tsang et al. Microbiol Spectr. 2023 Apr 24;e0190022. Genomic epidemiology can facilitate an understanding of evolutionary history and transmission dynamics of a severe acute respiratory